Something big is happening in American hospitals—and it’s not another shiny new device or a blockbuster drug. It’s a quiet, behind-the-scenes transformation driven by smart software that’s getting better at understanding how doctors think, how patients behave, and how diseases unfold.

The $38 billion U.S. commercial weight loss market is 15% larger than in 2020, but has had to pivot to adjust to huge competition from the popular GLP-1 drugs.

At no other time in the U.S. weight loss market history has one product so dominated the market as have the new GLP-1 weight loss drugs. American dieters have flocked to them, shunning commercial weight loss programs such as Weight Watchers, Medifast, as well as retail and MLM meal replacements.

Outpatient physical therapy is in demand, as the U.S. population ages. A stable reimbursement environment, private equity investment, and the popularity of PT as an alternative to opioids for pain management all contribute to a positive outlook through 2030.

An estimated 70 million Americans have insomnia, and 39 million suffer from obstructive sleep apnea (OSA), mostly undiagnosed. As obesity rates remain high, this problem is not likely to dissipate any time soon. Therefore, there is ample room for future growth of CPAP devices and sleep studies, performed at home or in specialized clinics.

Elective surgery is the key revenue-generating source for most hospitals, ambulatory surgery centers (ASCs) and other inpatient and outpatient centers. It is estimated that up to two-thirds of hospital revenue is generated by surgical procedures.

The healthcare landscape is undergoing a profound transformation, ushering in the era of digital health as the new norm.

The use of big data analytical tools offers enormous opportunities to collect large amounts of data for the development of therapeutic drugs. Big data in healthcare typically refers to data collection from different sources, including biometric systems, medical research, data analytical tools, and electronic medical records.

Telehealth soared during the pandemic in 2020 as consumers stayed home and communicated with their physicians via Zoom video calls and by phone, email and chat. The number of telehealth companies exploded. Then, in 2021-2023, as demand for the GLP-1 weight loss medications took off, many of these telehealth providers added weight loss plans based on access to these drugs, plus support.

Discover five fast-growing industries that are making waves in the business world, and learn which key segments offer the highest potential for revenue growth, based on new data from a variety of leading market research firms.